Hyperprogression After Immunotherapy in Patients With Malignant Tumors of Digestive System

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5921-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Outcome of Using Blood Alternatives and Surgery for Treating Jehovah's Witness Patients With Malignant Digestive Tumors

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2012English

Prognostic Significance of Pretreatment Plasma Fibrinogen Level in Patients With Digestive System Tumors: A Meta-Analysis

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2018English

P3.01-56 Hyperprogression and Pseudoprogression in Patients With Non-Small Cell Lung Cancer on Checkpoint Blocking Immunotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immunoreactivity of the 14F7 Mab Raised Against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors From Digestive System

ISRN Gastroenterology
2011English

Central Nerve System Malignant Tumors

IOSR Journal of Dental and Medical Sciences
2014English

Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

Trends in Cancer
Cancer ResearchOncology
2020English

High Prevelance of Human Parvovirus Infection in Patients With Malignant Tumors

Oncology Letters
Cancer ResearchOncology
2012English

Malignant Tumors in Families of Thyroid Cancer Patients

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1997English

4. Immunoelectrophoretic Analysis of Sera From Patients With Malignant Tumors

SEIBUTSU BUTSURI KAGAKU
1965English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy